Coombs test (also known as Coombs' test, antiglobulin test or AGT) refers to two clinical blood tests used in haematology and immunology.
The two Coombs tests:
- Direct Coombs test, also direct antiglobulin test or DAT.
- Indirect Coombs test, also indirect antiglobulin test or IAT.
Coombs test can refer to either the direct or indirect form. The form of the Coombs test may not be specified but it is usually clear from the clinical context or why the test was requested by a physician that the direct or indirect form is referred to.
Blood samples for Coombs tests are taken by phlebotomists, nurses or physicians by venipuncture. Coombs tests are done by trained laboratory staff. The clinical significance of the results are assessed by physicians.
Direct Coombs Test
The direct Coombs test (also known as the
direct antiglobulin test or DAT) is used to detect if antibodies or complement system factors have bound to RBC surface antigens
in vivo.
Examples of diseases that give a positive direct Coombs test
The direct Coombs test is used clinically when immune mediated
haemolytic anaemia (antibody-mediated destruction of RBCs) is suspected. A positive Coombs test indicates that an immune mechanism is attacking the patients own RBCs. This mechanism could be
autoimmunity,
alloimmunity or a drug induced immune mediated mechanism.
Alloimmune haemolysis
Autoimmune haemolysis
- Cold antibody autoimmune hemolytic anemia
Drug induced immune mediated haemolysis
(A memory device to remember that the DAT tests the RBCs and is used to test infants for haemolytic disease of the newborn is:
Rh Disease; R = RBCs, D = DAT.)
Laboratory method
The
patient's red blood cells (RBCs) are washed (the patients own
serum is washed away) and then incubated with
antihuman globulin (also known Coombs reagent). If immunoglobulin or complement factors have been fixed on to the RBC surface
in-vivo, the antihuman globulin will
agglutinate the RBCs and the direct Coombs test will be positive. (A visual representation of a positive direct Coombs test is shown in the upper half of the schematic).
Indirect Coombs test
The indirect Coombs test (also known as the
indirect antiglobulin test or IAT) can detect very low concentrations of antibodies. It is used to screen for antibodies in blood transfusion preparation and it is also used in antenatal care to screen pregnant women for antibodies that may cause
hemolytic disease of the newborn.
By diluting a serum containing antibodies the quantity of the antibody in the serum can be gauged. This is done by using doubling dilutions of the serum and finding what is the maximum dilution of test serum that is able to produce agglutination of relevant RBCs.
Examples of clinical uses of the indirect Coombs test
Blood transfusion preparation
The indirect Coombs test is used to screen for antibodies in the preparation of
blood for
blood transfusion. Donor blood and recipients blood must be
ABO and Rhesus D compatible. Donor blood for transfusion is also screened for infections in separate processes. Accuracy in all the stages is vital.
A blood sample from the recipient and a blood sample from every unit of
donor blood is screened for antibodies with the indirect Coombs test. Each sample is incubated against a wide range specialy selected RBCs that together exhibit a full range of surface antigens (ie
blood types).
The indirect Coombs test is used to test a sample of the recipients serum against a sample of the
blood donor's RBCs. This is sometimes called
cross-matching blood.
Antenatal antibody screening
The indirect Coombs test is used to screen antenatal women for
IgG antibodies, that are likely to pass through the
placenta into the foetal blood and cause
haemolytic disease of the newborn.
Laboratory method
The IAT is a two stage test. (A cross match is shown visually in the lower half of the schematic as an example of an indirect Coombs test).
First stage
Washed test
red blood cells (RBCs) are incubated with a test serum. If the serum contains
antibodies to
antigens on the RBC surface, the antibodies will bind onto the surface of the RBCs.
Second stage
The RBCs are washed three or four times with isotonic saline and then incubated with antihuman globulin. If antibodies have bound to RBC surface antigens in the first stage, RBCs will agglutinate when incubated with the
antihuman globulin (also known Coombs reagent) in this stage and the indirect Coombs test will be positive.
Coombs reagent
Coombs reagent (also known as
Coombs antiglobulin or
antihuman globulin) is used in both the direct Coombs test and the indirect Coombs test. Coombs reagent is antihuman
globulin. It is made by injecting human globulin into animals. Coombs reagent contains animal antibodies specific for human
immunoglobulins and human
complement system factors. More specific Coombs reagent or
monoclonal antibodies can be used.
History of the Coombs test
The Coombs test was first described in
1945 by
Cambridge immunologists Robin Coombs (whom it is named after), Arthur Mourant and Rob Race.
[Coombs RRA, Mourant AE, Race RR. A new test for the detection of weak and "incomplete" Rh agglutinins. Brit J Exp Path 1945;26:255-66.] Historically, it was done in
test tubes. Today, it is commonly done using
microarray technology and
gel electrophoresis.
Reference
External links
Transfusion medicine | Hematology | Immunology | Medical tests | Eponymous medical tests
Coombs-Test
Test de Coombs
Antikörpersuchtest
Anticorps irréguliers
Odczyn antyglobulinowy Coombsa